Target Name: CRIPT
NCBI ID: G9419
Review Report on CRIPT Target / Biomarker Content of Review Report on CRIPT Target / Biomarker
CRIPT
Other Name(s): Cysteine-rich PDZ-binding protein | Cysteine-rich interactor of PDZ three | cysteine-rich interactor of PDZ three | SSMDF | CRIPT_HUMAN | CXXC repeat containing interactor of PDZ3 domain | Cysteine-rich interactor of PDZ3 | Postsynaptic protein CRIPT | HSPC139 | cysteine-rich interactor of PDZ3 | postsynaptic protein CRIPT

CRIPT: Cysteine-rich PDZ-binding Protein with Diverse Functions

CRIPT (Cysteine-rich PDZ-binding protein) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and skin. It is characterized by its unique structure, which consists of a long tail that is composed of 25 amino acids and a cysteine residue at its end.

One of the most interesting aspects of CRIPT is its ability to interact with the protein PDZ (Pyruvate-regulated intracellular signaling protein), which is a key regulator of many cellular processes in the body. PDZ is a protein that can interact with a wide variety of targets, including other proteins and nucleic acids. This interaction between PDZ and CRIPT is important for understanding the mechanisms of many cellular processes that involve the regulation of protein levels and intracellular signaling.

CRIPT has also been shown to play a role in the regulation of inflammation and immune responses. In addition, it has been shown to be involved in the development and progression of certain diseases, such as cancer and neurodegenerative disorders.

Despite its potential importance, little is currently known about the specific functions of CRIPT. In part, this is because the study of this protein has been limited by the lack of available research resources and the difficulty of obtaining high-quality images of its structure. However, recent studies have shed some light on the behavior of CRIPT in different cellular contexts.

One of the most significant findings of these studies is the evidence for the existence of CRIPT-PDZ interactions in various cellular processes. For example, researchers have shown that CRIPT can interact with PDZ in a variety of cellular contexts, including the regulation of protein synthesis, DNA replication, and cell division. These interactions are important for understanding the mechanisms of many cellular processes that involve the regulation of protein levels and intracellular signaling.

In addition, studies have also shown that CRIPT is involved in the regulation of inflammation and immune responses. For example, researchers have shown that CRIPT can interact with PDZ in a way that is involved in the regulation of immune cell function and the development of certain diseases, such as cancer.

Overall, the study of CRIPT is an important area of research because of its potential involvement in the regulation of many cellular processes that are important for the health and survival of cells. Further studies are needed to fully understand the functions of CRIPT and its role in the regulation of cellular processes.

Protein Name: CXXC Repeat Containing Interactor Of PDZ3 Domain

Functions: As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in the cytoskeletal anchoring of DLG4 in excitatory synapses (By similarity)

The "CRIPT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CRIPT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CRISP1 | CRISP2 | CRISP3 | CRISPLD1 | CRISPLD2 | CRK | CRKL | CRLF1 | CRLF2 | CRLF3 | CRLS1 | CRMA | CRMP1 | CRNDE | CRNKL1 | CRNN | CROCC | CROCC2 | CROCCP2 | CROCCP3 | CROT | CRP | CRPPA | CRPPA-AS1 | CRTAC1 | CRTAM | CRTAP | CRTC1 | CRTC2 | CRTC3 | CRTC3-AS1 | CRX | CRY1 | CRY2 | CRYAA | CRYAB | CRYBA1 | CRYBA2 | CRYBA4 | CRYBB1 | CRYBB2 | CRYBB2P1 | CRYBB3 | CRYBG1 | CRYBG2 | CRYBG3 | CRYGA | CRYGB | CRYGC | CRYGD | CRYGGP | CRYGN | CRYGS | CRYL1 | CRYM | CRYM-AS1 | Cryptochrome | Crystallin | CRYZ | CRYZL1 | CRYZL2P | CRYZL2P-SEC16B | CS | CSAD | CSAG1 | CSAG2 | CSAG3 | CSAG4 | CSDC2 | CSDE1 | CSE1L | CSF1 | CSF1R | CSF2 | CSF2RA | CSF2RB | CSF2RBP1 | CSF3 | CSF3R | CSGALNACT1 | CSGALNACT2 | CSH1 | CSH2 | CSHL1 | CSK | CSKMT | CSMD1 | CSMD2 | CSMD2-AS1 | CSMD3 | CSN1S1 | CSN1S2AP | CSN1S2BP | CSN2 | CSN3 | CSNK1A1 | CSNK1A1L | CSNK1A1P1 | CSNK1D | CSNK1E